Showing results (441-450 of 638) with videos related to
Sort By:
Pageof 64
Emergency Medicine Australasia : EMA|August 11, 2005
Substance misuse, anxiety and depression and urgency of presentation to a public emergency department in AustraliaStuart A Kinner, Rosa Alati, Kerrianne Watt, et al.Journal of Thrombosis and Thrombolysis|April 6, 2022
Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patientsMatthew Williams, Tania Ahuja, Veronica Raco, et al.International Journal of Geriatric Psychiatry|September 28, 2022
Potential beneficial effects of masupirdine (SUVN-502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analysesRamakrishna Nirogi, Pradeep Jayarajan, Vijay Benade, et al.Quality Management in Health Care|October 2, 2015
The Implementation and Evaluation of the Patient Admission Prediction Tool: Assessing Its Impact on Decision-Making Strategies and Patient Flow Outcomes in 2 Australian HospitalsJulia L Crilly, Justin Boyle, Melanie Jessup, et al.Medical Science Educator|February 14, 2022
Characteristics of academic medicine change agents as revealed by 4th-year medical students' reflections-on-practiceDavid Green, Gauri Agarwal, Daniel M Lichtstein, et al.Interactive Cardiovascular and Thoracic Surgery|November 25, 2010
Cerebral monitoring in patients undergoing carotid endarterectomy using a triple assessment techniqueAhmed M Ali, David Green, Hany Zayed, et al.Thrombosis and Haemostasis|October 4, 2002
Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patientsMark T Reding, Sijin Lei, Howard Lei, et al.Thrombosis Research|June 7, 2011
Statins in the prevention of venous thromboembolism: a meta-analysis of observational studiesMenaka Pai, Natalie S Evans, Sanjiv J Shah, et al.Regional Anesthesia and Pain Medicine|April 17, 2018
Clotting-Factor Concentrations 5 Days After Discontinuation of WarfarinHonorio T Benzon, Yogen Asher, Mark C Kendall, et al.Lancet (London, England)|September 25, 2025
Treatment for Alzheimer's diseaseNick C Fox, Christopher Belder, Clive Ballard, et al.Pageof 64